相关实验视频
Updated: Sep 19, 2025

06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
337
在初始呈现时,急性严重性结肠炎的结果
Diogo Couto Sousa1,2, Samuel Raimundo Fernandes1,2, Sofia Saraiva1,2
1Serviço de Gastrenterologia e Hepatologia, Hospital Santa Maria, Unidade Local de Saúde de Santa Maria, Lisboa.
European journal of gastroenterology & hepatology
|June 18, 2025
概括
新发性性结肠炎 (UC) 患者经历了更长的住院时间和更多的感染,但整体结果与已确定的UC患者相似. 这一发现对于了解急性严重性结肠炎 (ASUC) 管理至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 急性严重性结肠炎 (ASUC) 影响20-25%的性结肠炎 (UC) 患者.
- 在三分之一的病例中,ASUC可能是UC的初始表现,这带来了独特的临床挑战.
- 很大一部分ASUC患者对药物治疗没有反应,可能需要手术.
研究的目的:
- 基于疾病发病的ASUC住院患者的临床结果进行比较:新发病与已确定的UC.
- 为了确定这两个群体之间的住院时间,治疗反应和不良事件的差异.
主要方法:
- 追溯队列研究,涉及185名患者住院治疗ASUC.
- 新发病和已建立的UC群体之间的人口和临床特征的比较.
- 对结果的分析包括住院时间,类固醇反应,需要救援治疗,切除术率,死亡率和再入院.
主要成果:
- 新发性UC患者住院时间较长 (19 vs. 12天),接受救援治疗的延迟较大 (11 vs. 6天).
- 在新发病组中,严重的细菌感染更频繁 (16%vs4%).
- 两组之间在类固醇反应,需要救援疗法,小肠切除术,死亡率或再接收率方面没有发现显著差异.
结论:
- 尽管在住院时间和感染率方面存在初始差异,但ASUC的主要临床结果在新发病和已确诊的UC患者之间是可比的.
- 不良结果的独立预测因素包括活跃吸烟,广泛的结肠炎,需要救援治疗和严重的细菌感染,而不是新发病状态.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
348
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
348
Inflammatory Bowel Disease V: Surgical Management
226
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
226
Chronic Bowel Disorders: Introduction
544
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
544
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Inflammatory Bowel Disease II: Crohn's Disease
402
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
402
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
432
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432

